Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
  • Users Online: 45
  • Home
  • Print this page
  • Email this page

   Instructions to the Authors


About the Journal |  Scope of the journal|  The Editorial Process |  Clinical trial registry Authorship Criteria |  Contribution Details |   Conflicts of Interest/ Competing Interests | Submission of Manuscripts | Preparation of Manuscripts | Copies of any permission(s) | Types of Manuscripts | Protection of Patients' Rights..Sending a revised manuscript | Reprints and proofs | Manuscript submission..Copyrights  Checklist Contributors' form

INSTRUCTIONS TO AUTHORS

 

Aims and scope

The Research in Pharmaceutical Sciences (RPS) is the official journal of the School of Pharmacy of Isfahan University of Medical Sciences. The journal publishes research reports, review articles, short communications and scientific commentaries on all aspects of the pharmaceutical sciences. Submission requirements specify that papers should be original, unpublished and not under consideration for publication elsewhere. This restriction does not apply to the results published as abstracts of communications, letters to editors, or as contributions to symposia.

 

Manuscript preparation

All manuscripts should be typed double-spaced with a 12-point font, including references, figure legends and tables, on page with margins of 2.5 cm on all sides. The text of the manuscript must be paginated, the first page being the title page. The file formats should be in Microsoft Word for Windows. Manuscripts should be assembled in the following order:

  • Title page: The full title of the paper without abbreviations. The title should be as brief and informative as possible, specifying clearly the content of the article. The title page should include the names and affiliations of all authors and a running title (not more than 50 characters including spaces). Different affiliations should be indicated by numerical superscription. The full address, including e-mail, telephone and fax, of the corresponding author should be given.
  •  Abstract: The abstract should contain a brief account of the question addressed in the paper, the principal methods and results, followed by the main conclusion(s) and must not exceed 250 words. Abbreviations and symbols should be explained in round brackets () on the first use. References should be avoided in the abstract. Authors are requested to assign 3-6 keywords to the manuscript, preferably taken from the Medical Subject Headings (MESH). These keywords should be typed at the end of the abstract. Also abstract should be provided with no title.
  • Introduction: The introduction should give a short and clear account of the background of the problem and the rationale of the investigation. Only previous works that have direct bearing on the present problem should be cited.
  • Materials and Methods: The methods must be described in sufficient details to allow the experiments to be interpreted and repeated by the readers. Published procedures and techniques should be cited unless significant modifications are involved. The methods are presented in sub-sections, usually defined by the experimental procedure. Exact specification of relevant materials and equipments must be given. Chemical terms must conform to IUPAC rules. Material and Methods section must be accompanied by the name of the manufacturer or distributor, location and state or country. This information must be stated in round brackets in the text, and not as a footnote. The last subsection should provide the methods of data analysis and statistical assessments.
  • Results: The results may be presented in tables, figures or schemes, which must be referred to in the accompanying text, using appropriate numbering. Tables should be numbered consecutively with Arabic numerals and the number should be followed by a brief descriptive caption, occupying not more than two lines, at the head of the table. Each table should be given on a separate page, paginated as part of the paper. Each column should have a heading and the units of measurement should be given in brackets (SI units) in the heading. Figures must be presented on separate pages in consecutive order using Arabic numerals. Each figure should be provided with an instructive title and explanatory information. The legend should be typed separately from the figures. Figures, photographs or computer drawn figures should be original, and of high quality, ready for direct reproduction. Figure legends/captions should be consistent with terminology or nomenclature used in the labeling of the Figures. Tables, figures and legends should not have frame around. Statistical tests of significance should be performed where appropriate indicating p values.
  • Discussion: The discussion section should contain a brief and pertinent interpretation of the results against the background of existing knowledge. Any assumption on which conclusions are based must be stated clearly. A review-like treatment, which reduces the impact on the reader, should be avoided.
  • Conclusion: The main conclusions of the study should be presented in a short conclusions section, which should stand alone.
  • Acknowledgements: The acknowledgements should be brief but should include reference to sources of financial and technical supports.
  • References: The references should be cited according to the "Vancouver Style". Using this system, references are numbered in order that they are cited in the text. For in text citation, parenthesis should be used. References are listed in numerical order at the end of the paper. Journal names are to be abbreviated as they are in the Cumulated Index Medicus. "In press" references may be used only if the journal that has accepted the manuscript is indicated. Personal communications and other unpublished and nonarchival references should not be included in the reference list. Instead, they should be put as footnotes to the text; the source should be stated, and the item dated. Examples of references are as follows:

        Journals:

Popplewell EJ, Innes VA, Lloyd-Hughes S, Jenkins EL, Khdir K, Bryant TN, et al. The effect of high-efficiency and standard vacuum-cleaners on mite, cat and dog allergen levels and clinical progress. Pediatr Allergy Immunol. 2000;11:142-148.

Russell FD, Coppell AL. In vitro enzymatic processing of radiolabelled big ET-1 in human kidney as a food ingredient. Biochem Pharmacol. 1998;55:697-701.

Books:

Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J. Molecular cell biology. 3rd ed. New York: Scientific American; 1995.

Chapter citation:

Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG, editor. Basic and clinical pharmacology. 6th ed. Norwalk, CN: Appleton and Lange; 1995. p. 361-380.

Short communications

The short communication should be no more than 1000 words, and could include two figures or tables. It should have at least 15 references. The abstract should not exceed 150 words. Short communications must report completed work, not preliminary findings: they are an alternative format for describing smaller pieces of work.

Back issue link on journal archives: http://rps.mui.ac.ir/index.php/jrps/issue/archive

Submission procedure

To submit a manuscript, log on to www.journalonweb.com/jrps/ and follow the online submission procedure. Before submitting a manuscript, please make sure you have the following information to hand in addition to your files: The first and last names and e-mail addresses of all authors and full contact information of any preferred peer reviewers (e-mail address, phone number and institution).

The editorial process

On submission, section editors review the submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the Journal of Research in Pharmaceutical Sciences readers are also liable to be rejected at this stage.Throughout the entire editorial process, Research in Pharmaceutical Sciences follows the best practice guidelines given by the Committee on Publication Ethics (COPE) (available at: http://publicationethics.org/files/Code%20of%20Conduct.pdf). 
Manuscripts that are found suitable for publication in Journal of Research in Pharmaceutical Sciences are sent to three or more expert reviewers. During submission, the contributor is requested to provide names of two qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within two days. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as soon as the entire issue is ready for uploading.

Copyrights

The entire contents of the Research in Pharmaceutical Sciences (RPS) are protected under Indian and international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported License. 

Ethics in animal and clinical investigations

Investigations using experimental animals must state in the Methods section that the research followed the Principles of Laboratory Animal Care. The authors must seek approval from the appropriate ethical committee. Investigation with human subjects must state in the Methods section that the research followed the tenets of the last update of Declaration of Helsinki and was approved by the institutional human experimentation committee or equivalent, and that informed consent was obtained.

Protection of Patients’ Right to Privacy

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The journal abides by ICMJE guidelines:

  1. Authors, not the journals nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.
  2. If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.

Article publication charge

All manuscripts submitted to the RPS journal are peer-reviewed in the normal way under editorial control.  Authors are asked to follow the details of journal charges and word count limits in the table below. Upon acceptance for publication a processing fee will be payable. Payment of this charge allows RPS to recover its processing, editorial, and production costs. Published papers appear electronically and are freely available from our website. Submitters who tend to pay in Iranian currency are kindly requested to deposit their payments into the account No. 580120000000004975761007 (SHEBA) at Bank Mellat. Please include the specific code (payment ID) for RPS (441130000000049) on your bank receipt. Kindly send a scanned copy of your receipt to the journal via rps@pharm.mui.ac.ir. Contributors out of Iran can electronically pay through secure Medknow, Wolters Kluwer submission portal.

Word count limits and article processing charges at one glance

These numbers show the publication fee according to the word count for Research in Pharmaceutical Sciences (RPS) journal.

Article Type

Abstract

Full Text

(including references, tables and figures)

Total of Illustrations (tables and figures)

Publication fee (for listed word limits)

Extra payment per 500 words

Short

Communications

150

850

2

100 USD

50 USD

1,500,000 IRR

1,000,000 IRR

Case Reports

150

850

5

100 USD

50 USD

1,500,000 IRR

1,000,000 IRR

Letters and Editorials

-

500

1

Free

Free

Original Articles

250

2750

5

200 USD

50 USD

3,000,000 IRR

1,000,000 IRR

Qualitative Research

250

3250

5

200 USD

50 USD

3,000,000 IRR

1,000,000 IRR

Review Articles

250

6750

Unlimited

200 USD

50 USD

3,000,000 IRR

1,000,000 IRR

Each extra figure/table is considered equivalent to 300 words.

The publication fees are considered as IR Rials for Iranian authors and US Dollars for other nationalities.

There will be a 50% discount of publication fee if both the first and the corresponding author would be affiliated to Isfahan University of Medical Sciences.

Upon request for fast tracking of the submitted manuscript, an additional payment of 3,000,000 IRR /200 USD should be considered, with the journal promising to send the decision letter within eight weeks.

There are no additional charges for color illustrations.

 

Top

 
What's New
Reference style (PPS)
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal